Jonathan R. Heyen

1.0k total citations
18 papers, 821 citations indexed

About

Jonathan R. Heyen is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jonathan R. Heyen has authored 18 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Immunology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jonathan R. Heyen's work include Chronic Myeloid Leukemia Treatments (3 papers), Immune Response and Inflammation (3 papers) and Stress Responses and Cortisol (2 papers). Jonathan R. Heyen is often cited by papers focused on Chronic Myeloid Leukemia Treatments (3 papers), Immune Response and Inflammation (3 papers) and Stress Responses and Cortisol (2 papers). Jonathan R. Heyen collaborates with scholars based in United States, United Kingdom and China. Jonathan R. Heyen's co-authors include Rodney W. Johnson, Chén Jìng, Nathan L. Sparkman, Jessica B. Buchanan, Brian N. Finck, Eileen Blasi, Aileen McHarg, Swasti Tiwari, Carolyn Ecelbarger and Ricardo Mourilhe‐Rocha and has published in prestigious journals such as Journal of Neuroscience, American Journal of Physiology-Heart and Circulatory Physiology and Physiology & Behavior.

In The Last Decade

Jonathan R. Heyen

18 papers receiving 808 citations

Peers

Countries citing papers authored by Jonathan R. Heyen

Since Specialization

Citations

This map shows the geographic impact of Jonathan R. Heyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan R. Heyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan R. Heyen more than expected).

Fields of papers citing papers by Jonathan R. Heyen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan R. Heyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan R. Heyen. The network helps show where Jonathan R. Heyen may publish in the future.

Co-authorship network of co-authors of Jonathan R. Heyen

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan R. Heyen. A scholar is included among the top collaborators of Jonathan R. Heyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan R. Heyen. Jonathan R. Heyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity 2021 ·Journal for ImmunoTherapy of Cancer ·(unknown), Pawel K. Dominik, (unknown), Sheng Ding, Wenjing Yang, Nadia S. Kurd, (unknown), Jonathan R. Heyen, (unknown), Zea Melton, Thomas Van Blarcom, Kevin C. Lindquist, Javier Chaparro‐Riggers, Shahram Salek‐Ardakani	96
2	CD40 agonist-induced IL-12p40 potentiates hepatotoxicity 2020 ·Journal for ImmunoTherapy of Cancer ·Caroline Bonnans, Graham D. Thomas, Wenqian He, (unknown), Wei Chen, (unknown), Jonathan R. Heyen, Bernard S. Buetow, Smitha Pillai, (unknown), Javier Chaparro‐Riggers, Shahram Salek‐Ardakani, Yan Qu	14
3	Off-the-shelf AlloCAR T™ cells targeting BCMA for the treatment of multiple myeloma 2019 ·Clinical Lymphoma Myeloma & Leukemia ·Cesar Sommer, Trevor Bentley, Janette Sutton, Jonathan R. Heyen, Julien Valton, Yajin Ni, (unknown), Thomas Van Blarcom, Julianne Smith, (unknown), Barbra J. Sasu	3
4	Validation and utility of the PhysioTel™ Digital M11 telemetry implant for cardiovascular data evaluation in cynomolgus monkeys and Beagle dogs 2016 ·Journal of Pharmacological and Toxicological Methods ·Jason Cordes, Jonathan R. Heyen, (unknown), (unknown), (unknown), Ahmed Shoieb, Jill Steidl‐Nichols	6
5	Characterization, Biomarkers, and Reversibility of a Monoclonal Antibody-induced Immune Complex Disease in Cynomolgus Monkeys (Macaca fascicularis) 2014 ·Toxicologic Pathology ·Jonathan R. Heyen, Jennifer L. Rojko, Mark G. Evans, Tom Brown, Walter F. Bobrowski, Allison Vitsky, (unknown), Niraj Tripathi, Sangeetha Bollini, Theodore Johnson, John Lin, Nasir Khan, Bora Han	22
6	Pan-FGFR Inhibition Leads to Blockade of FGF23 Signaling, Soft Tissue Mineralization, and Cardiovascular Dysfunction 2013 ·Toxicological Sciences ·Gina M. Yanochko, Allison Vitsky, Jonathan R. Heyen, Brad Hirakawa, Justine L. Lam, (unknown), Tim Nichols, (unknown), (unknown), Eileen Blasi	58
7	Cardiovascular differentiation of imatinib and bosutinib in the rat 2013 ·International Journal of Hematology ·Jonathan R. Heyen, Wenyue Hu, Joseph Jamieson, Stéphane Thibault, Minerva Batugo, Cho‐Ming Loi, Leigh Ann Burns‐Naas, Aileen McHarg, Bart Jessen	3
8	Therapy with TLR7 Agonists Induces Lymphopenia: Correlating Pharmacology to Mechanism in a Mouse Model 2012 ·Journal of Clinical Immunology ·(unknown), (unknown), (unknown), Peter Colman, Frances Burden, Carl Laxton, Nigel Horscroft, (unknown), Débora F. Rodrigues, (unknown), Jonathan R. Heyen, Mark Fidock, Mike Westby, Helen Bright	20
9	Mechanistic Investigation of Imatinib-Induced Cardiac Toxicity and the Involvement of c-Abl Kinase 2012 ·Toxicological Sciences ·Wenyue Hu, Shuyan Lu, Indrawan McAlpine, Joseph Jamieson, (unknown), Lisa D. Marroquin, Jonathan R. Heyen, Bart Jessen	33
10	Sunitinib, a Receptor Tyrosine Kinase Inhibitor, Increases Blood Pressure in Rats without Associated Changes in Cardiac Structure and Function 2011 ·Cardiovascular Therapeutics ·Francesco Blasi, Jonathan R. Heyen, Shem Patyna, (unknown), David A. Gutierrez, Ava John‐Baptiste, Jill Steidl‐Nichols, Aileen McHarg	23
11	Cardiovascular Effects in Rats following Exposure to a Receptor Tyrosine Kinase Inhibitor 2010 ·Toxicologic Pathology ·Shirley A. Aguirre, Jonathan R. Heyen, (unknown), Walter F. Bobrowski, Eileen Blasi	17
12	Effects of Chronic PPAR‐Agonist Treatment on Cardiac Structure and Function, Blood Pressure, and Kidney in Healthy Sprague‐Dawley Rats 2009 ·PPAR Research ·Eileen Blasi, Jonathan R. Heyen, (unknown), Aileen McHarg, Carolyn Ecelbarger, Swasti Tiwari	27
13	Time course of AQP-2 and ENaC regulation in the kidney in response to PPAR agonists associated with marked edema in rats 2008 ·Pharmacological Research ·Swasti Tiwari, Eileen Blasi, Jonathan R. Heyen, Aileen McHarg, Carolyn Ecelbarger	30
14	EFFECTS OF CHRONIC PPAR-AGONIST TREATMENT ON CARDIO-RENAL STRUCTURE, FUNCTION, AND BLOOD PRESSURE IN SPRAGUE–DAWLEY RATS 2007 ·Journal of Pharmacological and Toxicological Methods ·Eileen Blasi, Jonathan R. Heyen, (unknown), Aileen McHarg, (unknown), Carolyn Ecelbarger	1
15	Interleukin-6 Facilitates Lipopolysaccharide-Induced Disruption in Working Memory and Expression of Other Proinflammatory Cytokines in Hippocampal Neuronal Cell Layers 2006 ·Journal of Neuroscience ·Nathan L. Sparkman, Jessica B. Buchanan, Jonathan R. Heyen, Chén Jìng, (unknown), Rodney W. Johnson	255
16	Structural, functional, and molecular characterization of the SHHF model of heart failure 2002 ·American Journal of Physiology-Heart and Circulatory Physiology ·Jonathan R. Heyen, Eileen Blasi, Kristen J. Nikula, Ricardo Mourilhe‐Rocha, (unknown), Gregory E. Frierdich, John F. Van Vleet, (unknown), Ellen G. McMahon, Amy E. Rudolph	85
17	Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-κB 2000 ·Molecular Brain Research ·Jonathan R. Heyen, (unknown), Brian N. Finck, Rodney W. Johnson	115
18	Behavior of Adult and Aged Mice Before and After Central Injection of Interleukin-1β 1999 ·Physiology & Behavior ·(unknown), (unknown), Jonathan R. Heyen, Rodney W. Johnson	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact